Selected Publications

Sannigrahi MK, Raghav L, Rich DJ, Schrank TP, Califano JA, Lukens JN, Sun L, Morgan IM, Cohen RB, Lin A, Liu X, Brown EJ, You J, Mirabello L, Mishra SK, Shimunov D, Brody RM, Pearson AT, Gimotty PA, Diab A, Jalaly JB, Basu D.: Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancer. J Natl Cancer Inst 117: 1366-1376, Jul 2025.

Sun L, Marmarelis ME, Aggarwal C.: Management of Patients With EGFR Exon 20-Mutant Advanced Non-Small Cell Lung Cancer. J Clin Oncol 43(13), May 2025.

Cohen RB, Jimeno A, Hreno J, Sun L, Wallén-Öhman M, Millrud CR, Sanfridson A, Garcia-Ribas I.: Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors. Invest New Drugs May 2025.

Barsouk A, Elghawy O, Watts A, Reed-Guy L, Tompkins W, Chandrasekhara K, Grady CB, Iams W, Sun F, Liu G, Patel D, Nieva JJ, Marrone KA, Velcheti V, Liu SV, Patil T, Weiss J, Schwartzman W, Villaruz LC, Hermann A, Aisner DL, Hwang WT, Camidge DR, Sun L, Singh AP, Cohen RB, Aggarwal C, Langer CJ, Marmarelis ME.: Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis. Lung Cancer 203(108551), May 2025.

Elghawy O, Barsouk A, Reed-Guy L, Stalker M, Sussman J, Robinson K, Kosteva J, Singh A, Cohen RB, Langer C, Ciunci C, D'Avella C, Sun L, Marmarelis ME, Aggarwal C.: Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy. Clin Lung Cancer 26(2): 158-163.e2, March 2025.

Melina E Marmarelis 1 2, Dylan G Scholes 1 3, Tara L McWilliams 4 5, Wei-Ting Hwang 2 4 5, John Kosteva 1, Michael R Costello 1, Lova Sun 1 2, Aditi P Singh 1 2, Kelsey S Lau-Min 6, Abigail Doucette 2 3, Peter E Gabriel 2 3 7, Anthony O Martella 3, Megan A Roy 1 2, Jeffrey C Thompson 2 8, Roger B Cohen 1 2, David W Dougherty 1 2, Lawrence N Shulman 1 2 3, Corey J Langer 1 2, Justin E Bekelman 2 3 7, Erica L Carpenter 1 2, Charu Aggarwal 1 2 3: Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial. JCO Oncol Pract 20(12), Dec 2024.

Jacob B Reibel 1, Lova L Sun 1, Ravi B Parikh 1 2, Nadim Mahmud 3 4, Lainie P Martin 1, Rebecca A Hubbard 5, Ronac Mamtani 1: Real-world impact of the platinum chemotherapy shortage on US patients with advanced cancer. J Natl Cancer Inst 117: 1276-1278, Dec 2024.

Connor B Grady 1, Wei-Ting Hwang 1, Joshua E Reuss 2, Wade Iams 3, Amanda Cass 3, Geoffrey Liu 4, Devalben Patel 4, Stephen V Liu 2, Gabriela Liliana Bravo Montenegro 2, Tejas Patil 5, Jorge J Nieva 6, Amanda Herrmann 6, Kristen A Marrone 7, Vincent K Lam 7, William Schwartzman 8, Jonathan Dowell 8, Liza C Villaruz 9, Kelsey Leigh Miller 10, Jared Weiss 10, Fangdi Sun 11, Vamsidhar Velcheti 12, D Ross Camidge 5, Charu Aggarwal 13, Lova Sun 13, Melina E Marmarelis 13: Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer. Pharmacoepidemiol Drug Saf 33(12), Dec 2024.

Glenn J Hanna 1, Jamie Jabalee 2, John N Lukens 3, Lova Sun 3, Eleni M Rettig 4, Rocco Ferrandino 2nd 5, Marshall R Posner 5, Krzysztof J Misiukiewicz 5, David M Routman 6, Kathryn M Van Abel 6, Catherine Del Vecchio Fitz 2, Scott A Roof 5: Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer. Oral Oncol 158, Nov 2024.

Lova Sun 1, Roger B Cohen 2, A Dimitrios Colevas 3: Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC). Oral Oncol 158, Nov 2024.